US state laws on medical freedom and investigational stem cell procedures: a call to focus on state-based legislation

Simple item page
dc.citation.firstpage404en_US
dc.citation.issueNumber4en_US
dc.citation.journalTitleCytotherapyen_US
dc.citation.lastpage409en_US
dc.citation.volumeNumber26en_US
dc.contributor.authorMatthews, Kirstin R. W.en_US
dc.contributor.authorLowe, Samantha J.en_US
dc.contributor.authorMaster, Zubinen_US
dc.date.accessioned2024-07-25T20:55:14Zen_US
dc.date.available2024-07-25T20:55:14Zen_US
dc.date.issued2024en_US
dc.description.abstractThe premature marketing of investigational stem cell interventions (SCIs) is a growing market in the US. Several US states have passed legislation to permit and promote unproven and experimental SCIs for individuals with terminal or chronic diseases. These SCI medical freedom laws, which are largely based on right-to-try legislation, increase access to experimental SCIs with little to no oversight. They undermine federal regulatory authority and can compromise patient safety and informed decision-making. SCI medical freedom laws have gone largely unnoticed by scientific societies interested in the responsible translation of stem cell medicine. In this article, we analyze state SCI medical freedom laws and describe their detrimental impact on patients and society. We contend that scientific and medical societies are uniquely poised to advocate against state-based policy promoting unproven SCIs but recognize resource and other constraints to advocate for or against legislation in 50 states. We recommend societies establish coalitions and share resources to address state-based SCI medical freedom laws and other legislation surrounding unproven SCIs.en_US
dc.identifier.citationMatthews, K. R. W., Lowe, S. J., & Master, Z. (2024). US state laws on medical freedom and investigational stem cell procedures: A call to focus on state-based legislation. Cytotherapy, 26(4), 404–409. https://doi.org/10.1016/j.jcyt.2024.01.002en_US
dc.identifier.digital1-s20-S1465324924000203-mainen_US
dc.identifier.doihttps://doi.org/10.1016/j.jcyt.2024.01.002en_US
dc.identifier.urihttps://hdl.handle.net/1911/117484en_US
dc.language.isoengen_US
dc.publisherElsevieren_US
dc.rightsExcept where otherwise noted, this work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license.  Permission to reuse, publish, or reproduce the work beyond the terms of the license or beyond the bounds of fair use or other exemptions to copyright law must be obtained from the copyright holder.en_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.titleUS state laws on medical freedom and investigational stem cell procedures: a call to focus on state-based legislationen_US
dc.typeJournal articleen_US
dc.type.dcmiTexten_US
dc.type.publicationpublisher versionen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
1-s20-S1465324924000203-main.pdf
Size:
428.75 KB
Format:
Adobe Portable Document Format
Download
Collections
Faculty Publications
Baker Institute Publications